Finance

Lists
4527:TYO
रोहतो फर्मास्युटिकल
JP¥ २,७१२.५०
-०.६२%
(-१७.००) 1D
अक्टोबर ८, १५:२४:५८ GMT+९  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4527...
Open
JP¥ २,७३६
High
JP¥ २,७३८
Low
JP¥ २,६७६
Mkt. cap
६.४३ खरब
Avg. vol.
११.७१ लाख
Volume
५.७४ लाख
Dividend
१.७०%
Quarterly dividend
JP¥ ११
Ex-dividend date
२०२६ सेप्टेम्बर २९
P/E ratio
१९.२६
52-wk high
JP¥ ३,१२२
52-wk low
JP¥ २,२१८
EPS
JP¥ १४१
Shares outstanding
११.४० करोड
No. of employees
९ हजार
Open
JP¥ २,७३६
High
JP¥ २,७३८
Low
JP¥ २,६७६
Mkt. cap
६.४३ खरब
Avg. vol.
११.७१ लाख
Volume
५.७४ लाख
Dividend
१.७०%
Quarterly dividend
JP¥ ११
Ex-dividend date
२०२६ सेप्टेम्बर २९
P/E ratio
१९.२६
52-wk high
JP¥ ३,१२२
52-wk low
JP¥ २,२१८
EPS
JP¥ १४१
Shares outstanding
११.४० करोड
No. of employees
९ हजार
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
१ दिन पहिले
Rohto Pharmaceutical stock sets FY2031 growth targets
Profile
Rohto Pharmaceutical Co., Ltd. is a Japanese multinational corporation specializing in fast-moving consumer goods and pharmaceuticals, headquartered in Ikuno-ku, Osaka, Japan. The company primary focuses on skin and eye care products. They also produce cosmetics, supplements, and over-the-counter medications. Wikipedia
About रोहतो फर्मास्युटिकल
CEOKunio Yamada | Kunio Yamada
Employees९.२९ हजार
Founded१८९९
HeadquartersOsaka, Osaka, जापान
SectorPersonal care products
Last report
२०२६ अगस्ट ६
Fiscal period
Q1 2027
- / -
Revenue / Est. (JPY)
९१.६२ अरब / ८७.०५ अरब
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
८२.२९ अरब
८८.८१ अरब
९०.६५ अरब
९१.६२ अरब
Cost of goods sold
३६.९६ अरब
३७.६८ अरब
४०.२८ अरब
४०.०३ अरब
Cost of revenue
३६.९६ अरब
३७.६८ अरब
४०.२८ अरब
४०.०३ अरब
Research and development expenses
-
-
१३.७३ अरब
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३७.७१ अरब
३६.८८ अरब
१९.३९ अरब
३७.९३ अरब
Operating expense
३७.८३ अरब
३७.०३ अरब
४२.९० अरब
३८.०२ अरब
Total operating expenses
७४.७९ अरब
७४.७१ अरब
८३.१८ अरब
७८.०५ अरब
Operating income
७.५० अरब
१४.१० अरब
७.४७ अरब
१३.५७ अरब
Other non operating income
४३.९० करोड
११.६० करोड
४४.५० करोड
१९.५० करोड
EBT including unusual items
८.४७ अरब
१५.२२ अरब
८.०६ अरब
१४.८० अरब
EBT excluding unusual items
८.४८ अरब
१५.२४ अरब
८.१२ अरब
१४.४९ अरब
Income tax expense
२.७५ अरब
४.६५ अरब
१.९८ अरब
३.७५ अरब
Effective tax rate
३२.५०%
३०.५५%
२४.५८%
२५.३६%
Other operating expenses
-
-
-
-
Net income
५.८८ अरब
१०.६३ अरब
५.९७ अरब
१०.६५ अरब
Net profit margin
७.१५%
११.९७%
६.५८%
११.६२%
Earnings per share
-
-
-
-
Interest and investment income
२७.०० करोड
५७.३० करोड
७५.९० करोड
१.१५ अरब
Interest expense
-२८.६० करोड
-३१.१० करोड
-३७.१० करोड
-३२.०० करोड
Net interest expenses
-१.६० करोड
२६.२० करोड
३८.८० करोड
८३.३० करोड
Depreciation and amortization charges
-
-
७.६९ अरब
-
EBITDA
११.५४ अरब
१७.३९ अरब
११.८२ अरब
१७.९२ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू